Skip Navigation

Chen Elected Co-Chair of NCI's Prostate Cancer Task Force

Ronald Chen

June 16, 2020

Ronald Chen, MD, MPH, Brandmeyer Chair and Professor of Radiation Oncology, has been elected radiation oncology co-chair of the National Cancer Institute’s (NCI) National Clinical Trials Network (NCTN) Prostate Cancer Task Force. It is overseen by the Genitourinary Cancers Steering Committee, which meets monthly to address the design, prioritization and evaluation of concepts for phase II and phase III clinical trials in genitourinary cancers.

The task force is guided by the committee’s strategic priorities, which include addressing:

  • areas of unmet clinical need,
  • unanswered clinical questions,
  • and potential new approaches to disease treatment.

“The National Cancer Institute sponsors some of the most important clinical trials in all cancers, including prostate cancer. The Prostate Cancer Task Force is comprised of the foremost prostate cancer experts in the country and helps the NCI select the best trials that will have the biggest impact for patients,” Dr. Chen said.

As co-chair of the task force, Dr. Chen will help facilitate this process as well as support the NCI in establishing priorities for the types of clinical trials to conduct.

Explore more news, events and blog